Recursion Pharmaceuticals Inc Cl A
(RXRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 75,171 |
| Receivables | 0 | 0 | 0 | 151 |
| Other current assets | 0 | 0 | 0 | 1,076 |
| TOTAL | $0 | $0 | $0 | $76,398 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 30,085 |
| Other Non-Current Assets | 0 | 0 | 0 | 663 |
| TOTAL | $N/A | $N/A | $N/A | $30,748 |
| Total Assets | $0 | $0 | $0 | $101,431 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,261 |
| Accrued Expenses | 0 | 0 | 0 | 4,879 |
| TOTAL | $0 | $0 | $0 | $6,684 |
| Non-Current Liabilities | ||||
| Long Term Debt | 0 | 0 | 0 | 12,418 |
| TOTAL | $N/A | $N/A | $N/A | $14,696 |
| Total Liabilities | $0 | $0 | $0 | $24,587 |
| Shareholders' Equity | ||||
| Retained earnings | 0 | 0 | 0 | -126,595 |
| Other shareholders' equity | 0 | 0 | 0 | 201,109 |
| TOTAL | $0 | $0 | $0 | $76,844 |
| Total Liabilities And Equity | $0 | $0 | $0 | $101,431 |